Old Web
English
Sign In
Acemap
>
authorDetail
>
Nichola Downs
Nichola Downs
University Hospital Southampton NHS Foundation Trust
Medicine
Cisplatin
Gemcitabine
Pathology
Guadecitabine
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine chemotherapy (SPIRE): Randomized expansion phase as neoadjuvant therapy for bladder urothelial carcinoma.
2021
Journal of Clinical Oncology
Simon J. Crabb
Sarah Danson
James W.F. Catto
Syed A. Hussain
Denise Dunkley
Nichola Downs
Geoff N Saunders
Michelle Light
Naveed Sarwar
Deborah Enting
Alison J. Birtle
Amir El Ghzal
Bernadette Johnson
Robert Huddart
Gareth Griffiths
Show All
Source
Cite
Save
Citations (0)
Response to guadecitabine (SGI-110) combined with cisplatin and gemcitabine (GCG) in platinum refractory germ cell tumors (GCTs).
2020
Journal of Clinical Oncology
Simon J. Crabb
Robert Huddart
Emma Brown
Denise Dunkley
Nichola Downs
Cathy McDowell
James W.F. Catto
Gareth Griffiths
Sarah Danson
Alison Reid
Show All
Source
Cite
Save
Citations (2)
ProCAID: A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel and prednisolone chemotherapy (DP) in metastatic castration-resistant prostate cancer (mCRPC).
2020
Journal of Clinical Oncology
Simon J. Crabb
Gareth Griffiths
Ellice Marwood
Denise Dunkley
Nichola Downs
Karen Martin
Michelle Light
Josh Northey
Amy Whitehead
Emily C. Shaw
Alison J. Birtle
Amit Bahl
Tony Elliott
Charlotte Westbury
Santhanam Sundar
Angus Robinson
Satinder Jagdev
Satish Kumar
Vincent Khoo
Robert Jones
Show All
Source
Cite
Save
Citations (1)
1